Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Research & Development: 2017-2024

Historic Research & Development for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $54.9 million.

  • Puma Biotechnology's Research & Development rose 26.82% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.4 million, marking a year-over-year increase of 14.74%. This contributed to the annual value of $54.9 million for FY2024, which is 9.04% up from last year.
  • Latest data reveals that Puma Biotechnology reported Research & Development of $54.9 million as of FY2024, which was up 9.04% from $50.4 million recorded in FY2023.
  • Over the past 5 years, Puma Biotechnology's Research & Development peaked at $97.7 million during FY2020, and registered a low of $50.4 million during FY2023.
  • For the 3-year period, Puma Biotechnology's Research & Development averaged around $52.5 million, with its median value being $52.2 million (2022).
  • In the last 5 years, Puma Biotechnology's Research & Development dropped by 27.31% in 2022 and then grew by 9.04% in 2024.
  • Puma Biotechnology's Research & Development (Yearly) stood at $97.7 million in 2020, then fell by 26.40% to $71.9 million in 2021, then fell by 27.31% to $52.2 million in 2022, then fell by 3.56% to $50.4 million in 2023, then grew by 9.04% to $54.9 million in 2024.